159 related articles for article (PubMed ID: 32777298)
21. Coverage of pharmacogenetic tests by private health insurance companies.
Park SK; Thigpen J; Lee IJ
J Am Pharm Assoc (2003); 2020; 60(2):352-356.e3. PubMed ID: 31843376
[TBL] [Abstract][Full Text] [Related]
22. Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS.
Fargher EA; Eddy C; Newman W; Qasim F; Tricker K; Elliott RA; Payne K
Pharmacogenomics; 2007 Nov; 8(11):1511-9. PubMed ID: 18034616
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of pharmacogenomic evidence for drugs related to
Reeves AA; Hopefl R; Deb S
Drug Metab Pers Ther; 2023 Mar; 38(1):65-78. PubMed ID: 36257916
[TBL] [Abstract][Full Text] [Related]
24. Paediatric clinical research from the perspective of hospital pharmacists from France and Canada.
Guérin A; Tanguay C; Lebel D; Prot-Labarthe S; Bourdon O; Bussières JF
Int J Pharm Pract; 2014 Dec; 22(6):415-23. PubMed ID: 24602206
[TBL] [Abstract][Full Text] [Related]
25. ASHP statement on the pharmacist's role in clinical pharmacogenomics.
Am J Health Syst Pharm; 2015 Apr; 72(7):579-81. PubMed ID: 25788513
[No Abstract] [Full Text] [Related]
26. Residents' experiences in, and attitudes toward, the care of persons with AIDS in Canada, France, and the United States.
Shapiro MF; Hayward RA; Guillemot D; Jayle D
JAMA; 1992 Jul 22-29; 268(4):510-5. PubMed ID: 1619743
[TBL] [Abstract][Full Text] [Related]
27. [Pharmacogenetics of aminoglycoside ototoxicity: State of knowledge and practices - Recommendations of the Francophone Network of Pharmacogenetics (RNPGx)].
Lebreton L; Hennart B; Baklouti S; Trimouille A; Boyer JC; Becquemont L; Dhaenens CM; Picard N
Therapie; 2024 Jun; ():. PubMed ID: 38876950
[TBL] [Abstract][Full Text] [Related]
28. Use of plasmid-derived external quality control samples in pharmacogenetic testing.
van der Straaten T; Swen J; Baak-Pablo R; Guchelaar HJ
Pharmacogenomics; 2008 Sep; 9(9):1261-6. PubMed ID: 18781854
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetic Testing Options Relevant to Psychiatry in Canada: Options de tests pharmacogénétiques pertinents en psychiatrie au Canada.
Maruf AA; Fan M; Arnold PD; Müller DJ; Aitchison KJ; Bousman CA
Can J Psychiatry; 2020 Aug; 65(8):521-530. PubMed ID: 32064906
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenetics: has the time come for pharmacists to embrace and implement the science?
Beier MT; Panchapagesan M; Carman LE
Consult Pharm; 2013 Nov; 28(11):696-711. PubMed ID: 24217190
[TBL] [Abstract][Full Text] [Related]
31. [Perspectives of the use of pharmacogenetic tests in neurology and psychiatry].
Kostyuk GP; Zakharova NV; Reznik AM; Surkova EI; Ilinsky VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):131-135. PubMed ID: 31626230
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic information.
Chang JS; Pham DA; Dang MT; Lu Y; VanOsdol S; Shin J
J Med Libr Assoc; 2016 Jan; 104(1):58-61. PubMed ID: 26807054
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
García-González X; Salvador-Martín S
J Pers Med; 2021 Nov; 11(11):. PubMed ID: 34834533
[TBL] [Abstract][Full Text] [Related]
34. The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later.
Relling MV; Klein TE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Caudle KE
Clin Pharmacol Ther; 2020 Jan; 107(1):171-175. PubMed ID: 31562822
[TBL] [Abstract][Full Text] [Related]
35. Health regulatory communications of well-established safety-related pharmacogenomics associations in six developed countries: an evaluation of alignment.
Tan-Koi WC; Lim ES; Teo YY
Pharmacogenomics J; 2017 Mar; 17(2):121-127. PubMed ID: 26902540
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetic associations and evidence-based pharmacogenomics guidelines: supporting label and off-label use of drug-gene interaction data.
Kisor DF; Monte AA; Müller DJ
Pharmacogenomics; 2020 May; 21(7):427-430. PubMed ID: 32319356
[No Abstract] [Full Text] [Related]
37. Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines.
Abdullah-Koolmees H; van Keulen AM; Nijenhuis M; Deneer VHM
Front Pharmacol; 2020; 11():595219. PubMed ID: 33568995
[TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetic testing: time for clinical practice guidelines.
Amstutz U; Carleton BC
Clin Pharmacol Ther; 2011 Jun; 89(6):924-7. PubMed ID: 21508939
[No Abstract] [Full Text] [Related]
39. Psychiatric pharmacists' perception on the use of pharmacogenomic testing in the mental health population.
Shishko I; Almeida K; Silvia RJ; Tataronis GR
Pharmacogenomics; 2015; 16(9):949-58. PubMed ID: 26100610
[TBL] [Abstract][Full Text] [Related]
40. Are pharmacists from the province of Quebec ready to integrate pharmacogenetics into their practice.
Petit C; Croisetière A; Chen F; Laverdière I
Pharmacogenomics; 2020 Mar; 21(4):247-256. PubMed ID: 32180495
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
